AAAAAA

   
Results: 1-13 |
Results: 13
USE OF STEM-CELL FACTOR PLUS FILGRASTIM IMPROVES PBPC COLLECTION IN HEAVILY PRETREATED PATIENTS WITH LYMPHOMA OR HODGKINS-DISEASE
Authors: STIFF P EMMANOUILIDES C LUGER S HARMAN G LEMAISTRE CF BROWN R PERRY J MASON JR LIST A BENSINGER W FRETER D SCHENKEIN D BRANNAN C OLSON E WYRES M WHEELER C
Citation: P. Stiff et al., USE OF STEM-CELL FACTOR PLUS FILGRASTIM IMPROVES PBPC COLLECTION IN HEAVILY PRETREATED PATIENTS WITH LYMPHOMA OR HODGKINS-DISEASE, Experimental hematology, 25(8), 1997, pp. 359-359
UNUSUAL PATTERN OF RELAPSE AFTER DONOR LEUKOCYTE INFUSIONS (DLI) FOR RELAPSED CML - LACK OF GRAFT-V-LEUKEMIA (GVL) EFFECT FOR ISOLATED CHLOROMAS
Authors: PORTER D SCHENKEIN D RAUCH A LONGTINE J MILLER K ANTIN J
Citation: D. Porter et al., UNUSUAL PATTERN OF RELAPSE AFTER DONOR LEUKOCYTE INFUSIONS (DLI) FOR RELAPSED CML - LACK OF GRAFT-V-LEUKEMIA (GVL) EFFECT FOR ISOLATED CHLOROMAS, Blood, 90(10), 1997, pp. 4473-4473
THE ROLE OF SPLENIC IRRADIATION (XRT) PRIOR TO BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML)
Authors: JABRO G KOC Y MILLER K BOYLE T RAVALESE J SCHENKEIN D SPRAGUE K BERKMAN E
Citation: G. Jabro et al., THE ROLE OF SPLENIC IRRADIATION (XRT) PRIOR TO BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML), Blood, 90(10), 1997, pp. 1669-1669
VARICELLA-ZOSTER VIRUS-INFECTIONS (VZV) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - FREQUENCY, RISK-FACTORS, CLINICAL OUTCOME AND ANTIVIRAL PROPHYLAXIS
Authors: KOC Y MILLER K SCHENKEIN D SPRAGUE K BERKMAN E DESJARDIN J SYNDMAN D
Citation: Y. Koc et al., VARICELLA-ZOSTER VIRUS-INFECTIONS (VZV) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - FREQUENCY, RISK-FACTORS, CLINICAL OUTCOME AND ANTIVIRAL PROPHYLAXIS, Blood, 90(10), 1997, pp. 2420-2420
IMPROVED PBPC COLLECTION USING STEMGEN(R) (STEM-CELL FACTOR, SCF) ANDFILGRASTIM (G-CSF) COMPARED TO G-CSF ALONE IN HEAVILY PRETREATED LYMPHOMA (NNL) AND HODGKINS-DISEASE (HD) PATIENTS (PTS)
Authors: STIFF P GINGRICH R LUGER S BROWN RA LEMAISTRE CF PERRY J SCHENKEIN D LIST A MASON JR BENSINGER W WHEELER CA FRETER C MURPHYFILKINS R WYRES M PARKER W EMMANOUILIDES C
Citation: P. Stiff et al., IMPROVED PBPC COLLECTION USING STEMGEN(R) (STEM-CELL FACTOR, SCF) ANDFILGRASTIM (G-CSF) COMPARED TO G-CSF ALONE IN HEAVILY PRETREATED LYMPHOMA (NNL) AND HODGKINS-DISEASE (HD) PATIENTS (PTS), Blood, 90(10), 1997, pp. 2628-2628
PROLONGED COURSE OF ADJUSTED-DOSE INTRAVENOUS CYCLOSPORINE AND SHORT-COURSE OF METHOTREXATE TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
Authors: MILLER K SCHENKEIN D ERBAN J HURLEY C BERKMAN E
Citation: K. Miller et al., PROLONGED COURSE OF ADJUSTED-DOSE INTRAVENOUS CYCLOSPORINE AND SHORT-COURSE OF METHOTREXATE TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD), Blood, 86(10), 1995, pp. 1572-1572
IMMUNOGLOBULIN GENE ANALYSIS OF EBV NEGATIVE AIDS LYMPHOMA - RELATIONSHIP TO THE DISTINCT IG REPERTOIRES OF EARLY AND LATE STAGES OF HIV-INFECTION
Authors: PRZYBYLSKI G NG V MCGRATH M SCHENKEIN D MONROE J SILBERSTEIN LE
Citation: G. Przybylski et al., IMMUNOGLOBULIN GENE ANALYSIS OF EBV NEGATIVE AIDS LYMPHOMA - RELATIONSHIP TO THE DISTINCT IG REPERTOIRES OF EARLY AND LATE STAGES OF HIV-INFECTION, Blood, 86(10), 1995, pp. 3719-3719
PHASE-I TRIAL OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH GCSF PRIMED PERIPHERAL-BLOOD STEM-CELL RESCUE IN PATIENTS WITH ADVANCED CANCER
Authors: WECKSTEIN D SPRAGUE K HURLEY C KARP D BERKMAN E CURTIN P SCHENKEIN D SWEET M MILLER K
Citation: D. Weckstein et al., PHASE-I TRIAL OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH GCSF PRIMED PERIPHERAL-BLOOD STEM-CELL RESCUE IN PATIENTS WITH ADVANCED CANCER, Blood, 86(10), 1995, pp. 3881-3881
COMBINED IMMUNOTOXIN AND CHEMOTHERAPY FOR INITIAL TREATMENT OF AIDS LYMPHOMA
Authors: SCADDEN DT DOWEIKO J BERNSTEIN Z SCHENKEIN D LUSKEY B STRAM D ESSELTINE D LEVINE AM
Citation: Dt. Scadden et al., COMBINED IMMUNOTOXIN AND CHEMOTHERAPY FOR INITIAL TREATMENT OF AIDS LYMPHOMA, Blood, 84(10), 1994, pp. 10000163-10000163
SPLENIC IRRADIATION PRIOR TO HIGH-DOSE CHEMOTHERAPY AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: RAVALESE J MADOCJONES H LING M SCHENKEIN D ERBAN J MILLER K
Citation: J. Ravalese et al., SPLENIC IRRADIATION PRIOR TO HIGH-DOSE CHEMOTHERAPY AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, International journal of radiation oncology, biology, physics, 27, 1993, pp. 312-312
GM-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PSC) AND GM-CSF POST INFUSION AFTER HIGH-DOSE MELPHALAN, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION (TBI) FOR ADVANCED RELAPSED MULTIPLE-MYELOMA
Authors: STADTMAUER E SCHENKEIN D MILLER K SICKLES C BIGGS D POWLIS W FRIEDENBERG W WINTER J TALLMAN M LAZARUS H
Citation: E. Stadtmauer et al., GM-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PSC) AND GM-CSF POST INFUSION AFTER HIGH-DOSE MELPHALAN, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION (TBI) FOR ADVANCED RELAPSED MULTIPLE-MYELOMA, Blood, 82(10), 1993, pp. 10000264-10000264
A PHASE-I II TRIAL OF COMBINED IMMUNOCONJUGATE AND CHEMOTHERAPY FOR AIDS-RELATED LYMPHOMA/
Authors: SCADDEN DT DOWEIKO J SCHENKEIN D BERNSTEIN Z LEVINE AM BRESNAHAN J GERE J ESSELTINE D EPSTEIN C
Citation: Dt. Scadden et al., A PHASE-I II TRIAL OF COMBINED IMMUNOCONJUGATE AND CHEMOTHERAPY FOR AIDS-RELATED LYMPHOMA/, Blood, 82(10), 1993, pp. 10000386-10000386
ADJUSTED-DOSE CONTINUOUS-INFUSION CYCLOSPORINE-A TO PREVENT GRAFT-VERSUS-HOST DISEASE
Authors: MILLER K SCHENKEIN D COMENZO R ERBAN J FOGAREN T HIRSCH C BERKMAN E RABSON A
Citation: K. Miller et al., ADJUSTED-DOSE CONTINUOUS-INFUSION CYCLOSPORINE-A TO PREVENT GRAFT-VERSUS-HOST DISEASE, Blood, 82(10), 1993, pp. 10000419-10000419
Risultati: 1-13 |